US gainers
US losers
Hong Kong gainers
Hong Kong losers
Oct 20Latest
Oct 19
Oct 16
Oct 15
Oct 14
Oct 13
Oct 12
Oct 9
‹ Previous day
Next day ›
Top US Stock Gainers · Oct 19 · 30
Mon, Oct 19, 2026 · Close
Screen: share price of at least $5, market cap of roughly $2 billion or more, and a gain above 3% on the day; the 30 largest moves are shown. Turnover is estimated as volume × last price. Source: Yahoo Finance.
Disc Medicine
US IRON
78.93
+38.86%
Change +22.09
Turnover (est.) $664.7M
Market cap $3.03B
52-wk high 99.50
52-wk low 40.00
Cleveland-Cliffs
US CLF
14.11
+16.42%
Change +1.99
Turnover (est.) $1.19B
Market cap $8.05B
52-wk high 16.70
52-wk low 7.73
Veradermics
US MANE
122.23
+12.32%
Change +13.41
Turnover (est.) $170.4M
Market cap $5.11B
52-wk high 136.72
52-wk low 32.00
Agios Pharmaceuticals
US AGIO
34.90
+11.43%
Change +3.58
Turnover (est.) $62.2M
Market cap $2.08B
52-wk high 46.00
52-wk low 22.24
Parabilis Medicines
US PBLS
25.35
+11.43%
Change +2.60
Turnover (est.) $53.8M
Market cap $3.13B
52-wk high 42.49
52-wk low 22.66
Arcutis Biotherapeutics
US ARQT
31.89
+10.65%
Change +3.07
Turnover (est.) $181.7M
Market cap $4.01B
52-wk high 33.00
52-wk low 19.30
Change +5.32
Turnover (est.) $717.0M
Market cap $3.72B
52-wk high 143.16
52-wk low 4.81
Viridian Therapeutics
US VRDN
20.80
+9.30%
Change +1.77
Turnover (est.) $53.2M
Market cap $2.36B
52-wk high 34.29
52-wk low 13.18
MaxLinear
US MXL
77.11
+8.12%
Change +5.79
Turnover (est.) $292.1M
Market cap $6.99B
52-wk high 128.30
52-wk low 12.77
JFrog
US FROG
91.00
+7.94%
Change +6.69
Turnover (est.) $193.9M
Market cap $11.22B
52-wk high 105.76
52-wk low 34.05
Celldex Therapeutics
US CLDX
29.67
+7.77%
Change +2.14
Turnover (est.) $44.8M
Market cap $2.33B
52-wk high 45.14
52-wk low 22.10
Praxis Precision Medicines
US PRAX
260.17
+7.61%
Change +18.41
Turnover (est.) $190.4M
Market cap $7.26B
52-wk high 392.70
52-wk low 154.45
Pharvaris
US PHVS
29.77
+7.32%
Change +2.03
Turnover (est.) $27.1M
Market cap $2.09B
52-wk high 43.25
52-wk low 21.02
Warby Parker
US WRBY
24.98
+7.03%
Change +1.64
Turnover (est.) $97.8M
Market cap $3.09B
52-wk high 31.00
52-wk low 14.96
Pulse Biosciences
US PLSE
47.55
+7.02%
Change +3.12
Turnover (est.) $16.0M
Market cap $3.39B
52-wk high 58.90
52-wk low 12.56
Dyne Therapeutics
US DYN
15.23
+6.88%
Change +0.98
Turnover (est.) $49.7M
Market cap $2.84B
52-wk high 27.30
52-wk low 14.00
Tango Therapeutics
US TNGX
23.53
+6.76%
Change +1.49
Turnover (est.) $43.7M
Market cap $3.97B
52-wk high 34.39
52-wk low 6.69
Applied Digital
US APLD
19.25
+6.65%
Change +1.20
Turnover (est.) $688.5M
Market cap $5.82B
52-wk high 50.73
52-wk low 17.65
Kodiak Sciences
US KOD
91.35
+6.53%
Change +5.60
Turnover (est.) $94.9M
Market cap $5.74B
52-wk high 104.00
52-wk low 15.83
Summit Therapeutics
US SMMT
15.57
+6.43%
Change +0.94
Turnover (est.) $94.9M
Market cap $12.42B
52-wk high 29.23
52-wk low 12.07
Rambus
US RMBS
92.66
+6.20%
Change +5.41
Turnover (est.) $147.1M
Market cap $10.02B
52-wk high 174.10
52-wk low 77.89
Western Digital
US WDC
352.21
+6.09%
Change +20.21
Turnover (est.) $2.66B
Market cap $131.84B
52-wk high 799.87
52-wk low 117.23
Spyre Therapeutics
US SYRE
84.72
+6.03%
Change +4.82
Turnover (est.) $97.6M
Market cap $7.92B
52-wk high 110.17
52-wk low 21.14
Change +3.06
Turnover (est.) $64.0M
Market cap $2.55B
52-wk high 75.72
52-wk low 21.10
Strive
US ASST
25.54
+6.02%
Change +1.45
Turnover (est.) $205.6M
Market cap $2.58B
52-wk high 36.20
52-wk low 7.02
Silgan
US SLGN
40.07
+6.01%
Change +2.27
Turnover (est.) $80.2M
Market cap $4.23B
52-wk high 49.55
52-wk low 33.70
MBX Biosciences
US MBX
52.48
+5.79%
Change +2.87
Turnover (est.) $26.7M
Market cap $2.53B
52-wk high 72.64
52-wk low 13.22
Abercrombie & Fitch
US ANFNear 52-wk high
161.98
+5.69%
Change +8.72
Turnover (est.) $223.6M
Market cap $6.87B
52-wk high 162.69
52-wk low 65.45
Heartflow
US HTFL
51.02
+5.65%
Change +2.73
Turnover (est.) $72.4M
Market cap $4.44B
52-wk high 54.32
52-wk low 20.13
ACM Research
US ACMR
56.09
+5.63%
Change +2.99
Turnover (est.) $52.4M
Market cap $3.91B
52-wk high 127.19
52-wk low 28.46
The first standard report for a new stock is free. Valuation and “Why it jumped” are paid features; the cost is shown before you submit. Public reports that already exist open directly.
This page organizes public market data. It is not a recommendation list or investment advice. Quotes may be delayed or contain errors; rely on the exchange and your broker for official data.